esmo 2016: press brief on results of cabosun trial cabozantinib compared to sunitinib in rcc
Published 7 years ago • 486 plays • Length 6:26Download video MP4
Download video MP3
Similar videos
-
4:12
cabosun trial of cabozantinib - could it change how we treat frontline rcc?
-
11:19
esmo 2016: press brief on the results from the eortc 18071 randomized double-blind trial
-
2:12
results of a trial comparing cabozantinib and sunitinib in mrcc
-
1:44
dr. choueiri on cabosun trial results in rcc
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:43
rcc data at esmo 2020
-
9:39
esmo 2016: press brief on the monaleesa-2 clinical trial on breast cancer
-
3:09
should sunitinib still be used in the treatment of metstatic kidney cancer?
-
31:42
esmo 2016: press brief q&a on topics discussed at this year's meeting
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
2:38
checkmate 9er: cabo-nivo superior to sunitinib in extended follow-up results
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
5:08
cabosun trial of upfront cabozantinib in metastatic rcc
-
6:31
toni choueiri:
-
7:29
results from cabosun, meteor and javelin
-
2:05
esmo 2020 highlights on nivolumab cabozantinib as 1st line therapy for arcc: the checkmate 9er study